{"prompt": "['Short Title: ACADEMIC: ADT + Docetaxel vs ADT + Abiraterone', 'Version Date: 13MAR2019', '16.3 SAE Reporting Requirements', 'A MedWatch 3500A form must be completed to document each observed SAE and submitted', 'to compliance@hci.utah.edu as soon as possible, but no later than 1 working day of first', 'knowledge or notification of event.', 'The Research Compliance Office will appropriately report these SAEs to the DSMC and/or', 'the IRB of record according to the requirements described below:', 'DSMC Notifications:', 'Fatal or life-threatening events meeting the definition of an SAE will be reported within 7', 'calendar days after first knowledge of the event by the investigator.', 'All other events meeting the SAE criteria above will be reported within 15 calendar days', 'after first knowledge of the event by the investigator.', 'Events that meet expedited reporting (serious, unexpected suspected adverse reactions)', 'will be reported to the FDA and IRB, as applicable.', 'IRB Notification:', '1. Events will be submitted to the IRB of record per local guidelines.', '16.4', 'Reporting of Pregnancy', 'Although pregnancy is not considered an adverse event, it is the responsibility of investigators', \"or their designees to report the pregnancy of a male subjects' female partner as an unanticipated\", 'problem involving risk as noted above. Pregnancies or lactation that occurs during the course', 'of the trial or within 30 days of completing the trial must be reported to the DSMC, IRB, and', 'FDA as applicable. All female partners of subjects who become pregnant must be followed to', 'the completion/termination of the pregnancy. Pregnancy outcomes of spontaneous abortion,', 'missed abortion, fetal death, intrauterine death, miscarriage and stillbirth must be reported as', 'serious events.', '16.5', 'Protocol Amendments', 'Any amendments or administrative changes to an IRB approved protocol will not be initiated', 'without submission of an amendment for IRB review and approval.', 'These requirements for approval will in no way prevent any immediate action from being taken', 'by the investigator in the interests of preserving the safety of all subjects included in the trial.', 'Any amendments to the protocol that significantly affect the safety of subjects, scope of the', 'investigation, or the scientific quality of the study are required to submit the amendment for', 'FDA review.', '16.6', 'Protocol Deviations', 'A protocol deviation (or violation) is any departure from the defined procedures and treatment', 'plans as outlined in the protocol version submitted and previously approved by the IRB.', 'Protocol deviations have the potential to place participants at risk and can also undermine the', 'scientific integrity of the study thus jeopardizing the justification for the research. Protocol', 'deviations are unplanned and unintentional events.', 'Page 38 of 52']['Short Title: ACADEMIC: ADT + Docetaxel vs ADT + Abiraterone', 'Version Date: 13MAR2019', 'Because some protocol deviations pose no conceivable threat to participant safety or scientific', 'integrity, reporting is left to the discretion of the PI within the context of the guidelines below.', 'The sponsor requires the prompt reporting to HCI RCO of protocol deviations which are:', 'Exceptions to eligibility criteria.', 'Intended to eliminate apparent immediate hazard to a research participant or', 'Harmful (caused harm to participants or others, or place them at increased risk of', 'harm - including physical, psychological, economic, or social harm), or', 'Possible serious or continued noncompliance', '16.7', 'FDA Annual Reporting', 'This study is IND exempt therefore there are no annual reporting requirements to the FDA.', '16.8', 'Clinical Trials Data Bank', 'The study will be registered on http://clinicaltrials.gov and the NCI CTRP (Clinical Trials', 'Reporting Program) by the Clinical Trials Office.', '16.9', 'Record Keeping', 'Per 21 CFR 312.57, the Investigator records shall be maintained for a period of 2 years', 'following the date a marketing application is approved; or, if no application is filed or the', 'application is not approved, until 2 years after the investigation is discontinued and the FDA', 'is notified.', 'Page 39 of 52']\n\n###\n\n", "completion": "END"}